A similar clinic–pathologic relationship between SPARC expression and tumour progression has been reported in other malignancies (Porte et al, 1995; Massi et al, 1999; Thomas et al, 2000; Sakai et al, 2001; Yamanaka et al, 2001; Yamashita et al, 2003). This evidence concerns the gene SPARC and neoplasm.